Compare Waste Management, Inc. (WM) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Waste Management, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? Waste Management, Inc. trades at $208.83 (market cap $83.98B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: Waste Management, Inc. is far larger — about 8.3× State Street SPDR S&P Biotech ETF's market cap, and Waste Management, Inc. pays a 1.8% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Waste Management, Inc. for 130 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| WM | XBI | |
|---|---|---|
Market Cap | $83.98B | $10.11B |
Volume | 2,182,180 | 12,903,266 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $246.51 | $169.55 |
52-Week Low | $196.77 | $104.99 |
Typical Hold Time | 130 Days | 38 Days |
Enterprise Value | $106.78B | — |
Dividend Yield | 1.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
WM trades at $210.10, up 0.56% today, with a bullish technical signal despite mixed moving average indicators. The company reported revenue of $25.20 billion in 2025 and maintains strong profitability with an 11.12% net income margin. Recent earnings show two beats and one miss, with Q3 2026 results expected soon. Analyst sentiment is positive with 54% buy ratings and no sell recommendations.
Outlook remains favorable due to consistent cash flow growth and strategic acquisitions, though elevated debt levels and competitive pressures pose risks. The stock offers a reliable dividend, with the next payment scheduled for September 2026. Investors should monitor Q3 earnings for confirmation of growth trajectory amid economic uncertainties.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
